Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Fatty Acids in Living Donor Liver Transplantation
NCT04030065Phase 2Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Dec 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omega-3 fatty acid in Early allograft dysfunction (EAD), sponsored by Institute of Liver and Biliary Sciences. Status: unknown.
02
Drugs
omega-3 fatty acid
03
Conditions
Early allograft dysfunction (EAD)
Beyond the preview
Go deeper on NCT04030065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04030065.